< back to search

Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.

Pavelka, Karel   •   Kivitz, Alan   •   Dokoupilova, Eva   •   Blanco, Ricardo   •   Maradiaga, Marco   •   Tahir, Hasan   •   Pricop, Luminita   •   Andersson, Mats   •   Readie, Aimee   •   Porter, Brian

published in: Arthritis research & therapy



endpoint

Secukinumab has (optional: compared with placebo) proved to be better.
general condition better


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection
conservative therapy → injection therapy
conservative therapy → injection therapy

publication details

10.1186/s13075-017-1490-y
pubmed
29273067
2017
Journal Article
randomized controlled trial
yes
prospective
1+

▼
▲